Last reviewed · How we verify
NCT05745870
Creatine Supplementation and Resistance Training in Premenopausal Females
Phase 1 trial testing Creatine Monohydrate Supplementation in Health Behavior in 27 participants. Completed in 12 May 2023.
12 May 2023
Quick facts
| Lead sponsor | University of Idaho |
|---|---|
| Phase | Phase 1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 27 |
| Start date | 20 January 2023 |
| Primary completion | 12 May 2023 |
| Estimated completion | 12 May 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Creatine Monohydrate Supplementation
Conditions studied
- Health Behavior — all drugs for Health Behavior →
Sponsor
University of Idaho
Who can join
Adults 18 to 22, female only, with Health Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to determine the effects of creatine monohydrate and resistance training on lean mass, sleep, muscular strength, and perceived menstrual cycle symptoms in untrained premenopausal females. The main questions it aims to answer are: 1) Does creatine monohydrate supplementation improve body composition, muscular strength, and sleep? 2) Does creatine monohydrate decrease perceived menstrual cycle symptoms compared to a placebo control? Participants will be asked to consume creatine monohydrate daily for 42 consecutive days and well as perform a daily ovulation test. Pre and post testing will include assessments of urine specific gravity to determine hydration status, body composition testing, muscular strength testing and questionnaires. Researchers will compare creatine monohydrate supplementation to a maltodextrin control to see if body composition, sleep, muscular strength, and perceived menstrual cycle symptoms are improved following 6-weeks.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Creatine Improves Total Sleep Duration Following Resistance Training Days versus Non-Resistance Training Days among Naturally Menstruating Females.
Aguiar Bonfim Cruz AJ, Brooks SJ, Kleinkopf K, Brush CJ, et al · · 2024 · cited 5× · PMID 39203908 · DOI 10.3390/nu16162772
Verify or expand the search:
- PubMed search for NCT05745870
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Health Behavior
Currently open trials in the same condition.
- NCT07466797 — The eHealth Integrated Maternal Physical Activity Programme in Prenatal Care Trial (E-IMPACT) · NA · recruiting
- NCT07248904 — The Effect of a Transtheoretical Model-Based Educational Intervention on First-Year Nursing Students' HPV Knowledge, Hea · NA · recruiting
- NCT07224412 — A Digital Intervention to Promote Preschool Nutrition and Activity: The eHEROs Study · NA · recruiting
- NCT07262840 — Health Behavior Change in High-Risk Colorectal Cancer Individuals · NA · recruiting
- NCT07226271 — Consumer Perceptions of Alcoholic Beverages · NA · recruiting
Other University of Idaho trials
Trials by the same sponsor.
- NCT06919718 — Impact of Vitamin D Supplements on Mental Health and Milk Composition in Mothers Living in Idaho · NA · recruiting
- NCT06721468 — Trout Consumption in Young Children and Families and Brain Health · NA · recruiting
- NCT05951491 — Improving Arm Function Using Wearable Exoskeletons · NA · unknown
- NCT05986539 — Early Life Feeding Exposure and Infant Immune and Health Status. · recruiting
- NCT05619445 — Feasibility of Egg-Based Diet Interventions and Assessing Perinatal Mental Health · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05745870 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Idaho
- Last refreshed: 7 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05745870.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing